[
  {
    "ts": null,
    "headline": "IDEXX Laboratories Touts “Exceptional” Q4, Targets 8%-10% 2026 Growth at BofA Summit",
    "summary": "IDEXX Laboratories (NASDAQ:IDXX) executives highlighted what they described as “exceptional” fourth-quarter results and outlined key priorities for 2026 during Bank of America’s 2026 Animal Health Summit. The discussion featured Executive Vice President and CFO Andrew Emerson and Executive Vice Pres",
    "url": "https://finnhub.io/api/news?id=b2ae8ec232cd40f002f15932580881167c8b9e1efb5186004e33a2265a93f456",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772258866,
      "headline": "IDEXX Laboratories Touts “Exceptional” Q4, Targets 8%-10% 2026 Growth at BofA Summit",
      "id": 139261018,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories (NASDAQ:IDXX) executives highlighted what they described as “exceptional” fourth-quarter results and outlined key priorities for 2026 during Bank of America’s 2026 Animal Health Summit. The discussion featured Executive Vice President and CFO Andrew Emerson and Executive Vice Pres",
      "url": "https://finnhub.io/api/news?id=b2ae8ec232cd40f002f15932580881167c8b9e1efb5186004e33a2265a93f456"
    }
  }
]